The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index; 23 of the 57 sources its claims cite were checked for support.
A randomised controlled trial of acceptance and commitment therapy plus usual care compared to usual care alone for improving psychological health in people with motor neuron disease (COMMEND): study protocol.
Open accessAbstract
Background: Motor neuron disease (MND) is a rapidly progressive, fatal neurodegenerative disease that predominantly affects motor neurons from the motor cortex to the spinal cord and causes progressive wasting and weakening of bulbar, limb, abdominal and thoracic muscles. Prognosis is poor and median survival is 2-3 years following symptom onset. Psychological distress is relatively common in people living with MND. However, formal psychotherapy is not routinely part of standard care within MND Care Centres/clinics in the UK, and clear evidence-based guidance on improving the psychological health of people living with MND is lacking. Previous research suggests that Acceptance and Commitment Therapy (ACT) may be particularly suitable for people living with MND and may help improve their psychological health.Aims: To assess the clinical and cost-effectiveness of ACT modified for MND plus usual multidisciplinary care (UC) in comparison to UC alone for improving psychological health in people living with MND.Methods: The COMMEND trial is a multi-centre, assessor-blind, parallel, two-arm RCT with a 10-month internal pilot phase. 188 individuals aged ≥ 18 years with a diagnosis of definite, laboratory-supported probable, clinically probable, or possible familial or sporadic amyotrophic lateral sclerosis, and additionally the progressive muscular atrophy and primary lateral sclerosis variants, will be recruited from approximately 14 UK-based MND Care Centres/clinics and via self-referral. Participants will be randomly allocated to receive up to eight 1:1 sessions of ACT plus UC or UC alone by an online randomisation system. Participants will complete outcome measures at baseline and at 6- and 9-months post-randomisation. The primary outcome will be quality of life at six months. Secondary outcomes will include depression, anxiety, psychological flexibility, health-related quality of life, adverse events, ALS functioning, survival at nine months, satisfaction with therapy, resource use and quality-adjusted life years. Primary analyses will be by intention to treat and data will be analysed using multi-level modelling.Discussion: This trial will provide definitive evidence on the clinical and cost-effectiveness of ACT plus UC in comparison to UC alone for improving psychological health in people living with MND.Trial Registration: ISRCTN Registry, ISRCTN12655391. Registered 17 July 2017, https://www.isrctn.com/ISRCTN12655391 .Protocol Version: 3.1 (10/06/2020).
Overview
CoChat Summary
## TL;DR
This is a study protocol for the COMMEND randomized controlled trial testing acceptance and commitment therapy (ACT) plus usual multidisciplinary care versus usual care alone for people with motor neuron disease (MND). The trial will assess clinical and cost-effectiveness, with the primary outcome being quality of life at 6 months.
## Key findings
- The planned trial will recruit 188 people aged ≥ 18 years with MND from about 14 UK MND Care Centres/clinics plus self-referral.
- Participants will be randomized to up to eight 1:1 ACT sessions plus usual care or usual care alone; the primary endpoint is quality of life at 6 months post-randomization.
- The sample size is powered to detect an effect size of 0.44 standard deviations with 90% power at a 5% two-sided alpha, assuming 20% attrition at 6 months.
- The protocol states the trial will also examine cost-effectiveness (including quality-adjusted life years) and secondary outcomes such as depression, anxiety, psychological flexibility, adverse events, ALS functioning, survival at 9 months, satisfaction with therapy, and caregiver burden.
## Methods
- Design: Multi-centre, assessor-blind, parallel, two-arm randomized controlled trial with a 10-month internal pilot phase; allocation is 1:1 stratified by site, and primary analyses are intention to treat using multi-level mixed effects models.
- Sample/data: 188 adults with definite/laboratory-supported probable/clinically probable/possible familial or sporadic ALS, plus progressive muscular atrophy and primary lateral sclerosis variants; recruitment from approximately 14 UK sites and self-referral. Caregivers can also participate if present, and therapists are study staff delivering the intervention.
- Intervention/comparison: ACT modified for MND, delivered in up to eight 1:1 sessions over 4 months, versus usual multidisciplinary care as outlined in NICE NG42; outcomes are collected at baseline, 6 months, and 9 months.
## Limitations
- The paper explicitly states limitations of a non-active control arm, potential unblinding of outcome assessors, and a relatively short follow-up period.
- It also notes that the short follow-up means the study will not be able to examine longer-term treatment effects.
- Evident from the protocol: because the intervention is compared with usual care rather than an active psychotherapy control, any benefit may be hard to attribute specifically to ACT rather than non-specific effects such as support; this is stated in the paper.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
13 Valid · 3 Not valid · 17 Not checked · 23 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“One hundred eighty-eight plwMND will be recruited from approximately 14 sites. This will allow detection of an effect size of 0.44 standard deviations, with a two-sided alpha of 5% and 90% power.”
§ A randomised controlled trial of acceptance and commitment therapy plus usual care compared to usual care alone for improving psychological health in people with motor neuron disease (COMMEND): study protocol > Qualitative component PlwMND and study therapists will be asked to anonymously complete a qualitative satisfaction questionnaire at 6 months follow-up and the end of intervention delivery, respectively, to further examine the acceptability and feasibility of ACT and UC. The satisfaction questionnaire for plwMND in the intervention arm will examine satisfaction with ACT and its suitability and relevance to plwMND, perceived benefits and limitations of the intervention, difficulties in implementing the intervention in their everyday lives, and any recommendations for revising the intervention. The version for those in the control arm will assess the acceptability and feasibility of the psychological aspects of their management within UC rather than all aspects of their management. Questions will focus on what kind of psychological support participants felt they needed and what they actually received, what was helpful and what was not, and what other psychological support would have been helpful. The satisfaction questionnaire for therapists will explore how ACT was delivered in practice (e.g. treatment fidelity, ease of delivering ACT for plwMND, difficulty of skills for participants to learn, etc.). If plwMND are unable to complete the written questionnaire (either via post, email or online) due to MND-related difficulties, they will be invited to complete the questionnaire verbally via telephone, videoconference, or face-to-face interview with an independent member of the research team. > Sample size
What the sources say
- Not checked — no full text of the sourcecites [59] Lenglet T, Lacomblez L, Abitbol JL, Ludolph A, Mora JS, Robberecht W, et al. A phase II−III trial of olesoxime in subjects with amyotrophic lateral sclerosis. Eur J Neurol. 2014;21(3):529–36. source
- Disputedcites [60] Kuyken W, Byford S, Byng R, Dalgleish T, Lewis G, Taylor R, et al. Study protocol for a randomized controlled trial comparing mindfulness-based cognitive therapy with maintenance anti-depressant treatment in the prevention of depressive relapse/recurrence: the PREVENT trial. Trials. 2010;11(1):99. sourceExperimental — accuracy not yet measured
The Methods/Design > Sample size section describes a depression-relapse trial with 420 participants, not 188 people with MND, and gives a detectable secondary-outcome effect size of 0.40, not 0.44. The Setting, participants, recruitment and randomization section specifies four recruitment sites, not approximately 14. The sample-size prose states 80% power, although its Table 1 note says 90%; neither supports the claimed MND calculation. Page numbers are unavailable in our copy. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
- Could not verifycites [61] A-Tjak JGL, Davis ML, Morina N, Powers MB, Smits JAJ, Emmelkamp PMG. A Meta-Analysis of the Efficacy of Acceptance and Commitment Therapy for Clinically Relevant Mental and Physical Health Problems. Psychother Psychosom. 2015;84(1):30–6. sourceExperimental — accuracy not yet measured
The Methods section describes how trials were selected for an ACT meta-analysis, and the Results report pooled effect sizes—not a recruitment or power calculation for people with MND. Searches for 188 participants, 14 sites, an effect size of 0.44, and 90% power found no supporting passage in our copy; page numbers were unavailable. (LLM, conf=0.78)
plainn = 188- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“therapists within Improving Access to Psychological Therapy services frequently lack knowledge of and familiarity with MND – an important factor that was highlighted in our previous qualitative work that examined plwMND’s preferences for psychological interventions [15].”
§ A randomised controlled trial of acceptance and commitment therapy plus usual care compared to usual care alone for improving psychological health in people with motor neuron disease (COMMEND): study protocol > Introduction > Background and rationale
What the sources say
- Partly supportedcites [15] Weeks KR, Gould RL, Mcdermott C, Lynch J, Goldstein LH, Graham CD, et al. Needs and preferences for psychological interventions of people with motor neuron disease. Amyotroph Lateral Scler Front Degener. 2019;20(7–8):521–31. sourceExperimental — accuracy not yet measured
In “Unfamiliar territory” (page unavailable), participants described a lack of MND knowledge among non-MND healthcare professionals. The Discussion (page unavailable) includes psychological therapists among professionals who may benefit from MND training. The paper does not identify IAPT therapists specifically or establish how frequently they lack that knowledge. (LLM, conf=0.87)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“there is evidence that ACT processes such as psychological flexibility predict functioning and quality of life in MND [25] and other progressive, incurable and/or life-limiting conditions, including muscle disorders [26–28], Duchenne muscular dystrophy [29] and palliative care populations [30].”
§ A randomised controlled trial of acceptance and commitment therapy plus usual care compared to usual care alone for improving psychological health in people with motor neuron disease (COMMEND): study protocol > Introduction > Background and rationale
What the sources say
- Not checked — no full text of the sourcecites [25] Pagnini F, Phillips D, Bosma CM, Reece A, Langer E, Langer E. Mindfulness, physical impairment and psychological well-being in people with amyotrophic lateral sclerosis. Psychol Health. 2015;30(5):503–17. source
- Not matchedcites [26] Graham C. Explaining and changing adverse illness perceptions in people with muscle disease. Kings College London; 2012.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not checked — no full text of the sourcecites [27] Graham CD, Rose MR, Hankins M, Chalder T, Weinman J. Separating emotions from consequences in muscle disease: Comparing beneficial and unhelpful illness schemata to inform intervention development. J Psychosom Res. 2013;74(4):320–6. source
- Supportedcites [28] Graham CD, Gouick J, Ferreira N, Gillanders D. The influence of psychological flexibility on life satisfaction and mood in muscle disorders. Rehabil Psychol. 2016;61(2):210–7. source
The Abstract reports that psychological flexibility predicted change in life satisfaction over four months in people with muscle disorders. This source is cited for the muscle-disorders portion of the sentence, not for MND, Duchenne muscular dystrophy, or palliative care populations. (LLM, conf=0.91)
- Partly supportedcites [29] Graham CD, Rose MR. What explains high life satisfaction in men living with Duchenne muscular dystrophy? A preliminary study to inform psychological intervention. Muscle Nerve. 2017;56(1):163–6. sourceExperimental — accuracy not yet measured
The Results report that psychological-flexibility measures differentiated men with Duchenne muscular dystrophy who had high versus low life satisfaction. The study does not establish that these processes predict functioning, and its group comparison does not establish prospective prediction of quality of life. (LLM, conf=0.84)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“there is emerging preliminary evidence that ACT might have advantages over conventional CBT through improved engagement, retention and durability of effects [31–34].”
§ A randomised controlled trial of acceptance and commitment therapy plus usual care compared to usual care alone for improving psychological health in people with motor neuron disease (COMMEND): study protocol > Introduction > Background and rationale
What the sources say
- Not checked — no full text of the sourcecites [31] Pakenham KI, Fleming M. Relations between acceptance of multiple sclerosis and positive and negative adjustments. Psychol Health. 2011;26(10):1292–309. source
- Partly supportedcites [32] Veehof MM, Trompetter HR, Bohlmeijer ET, Schreurs KMG. Acceptance- and mindfulness-based interventions for the treatment of chronic pain: a meta-analytic review. Cogn Behav Ther. 2016;45(1):5–31. sourceExperimental — accuracy not yet measured
The Main findings section reports that effects of acceptance- and mindfulness-based interventions generally increased at follow-up, whereas a cited CBT meta-analysis found only its mood effect maintained. This offers indirect support for greater durability, but not specifically for ACT. The Comparison with active treatments section finds no significant advantage over CBT, and the passages do not establish better engagement or retention. (LLM, conf=0.85)
- Supportedcites [33] Clarke S, Kingston J, James K, Bolderston H, Remington B. Acceptance and commitment therapy group for treatment-resistant participants: a randomized controlled trial. J Context Behav Sci. 2014;3(3):179–88. source
The Attrition section reports significantly fewer dropouts during ACT than during CBT-based treatment as usual, including five CBT participants who attended no sessions. The Discussion reports better maintenance of ACT gains at six-month follow-up and cautiously suggests ACT may be more acceptable to treatment-resistant clients. Together, these support the claim as preliminary evidence, rather than an established advantage across all settings. (LLM, conf=0.88)
- Partly supportedcites [34] Wetherell JL, Liu L, Patterson TL, Afari N, Ayers CR, Thorp SR, et al. Acceptance and commitment therapy for generalized anxiety disorder in older adults: a preliminary report. Behav Ther. 2011;42(1):127–34. sourceExperimental — accuracy not yet measured
The Results (Treatment Effects; page not provided) report that all 7 ACT participants completed therapy, compared with 5 of 9 CBT participants, providing preliminary support for a retention advantage in older adults with GAD. ACT gains remained stable at follow-up, but CBT outcomes were also stable; the paper does not establish better durability or improved treatment engagement relative to CBT. The Method (Procedure; page not provided) says the sample was too small for between-group statistical comparisons. (LLM, conf=0.86)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“quality of life in MND (and hence psychological health) has been found to be more associated with psychological/existential factors than physical function/strength [49]”
§ A randomised controlled trial of acceptance and commitment therapy plus usual care compared to usual care alone for improving psychological health in people with motor neuron disease (COMMEND): study protocol > Outcomes
What the sources say
- Not checked — no full text of the sourcecites [49] Simmons Z, Bremer BA, Robbins RA, Walsh SM, Fischer S. Quality of life in ALS depends on factors other than strength and physical function. Neurology. 2000;55(3):388–92. source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
4 more claims
Create a free account to see all 56 claims and to verify the 2 references still open.
- It may state two separate claims as one. 21
- Probably not a substantial claim. 38
Citations
Cites
Using thematic analysis in psychology
Braun, V., & Clarke, V. (2006) · Qualitative Research in Psychology · doi:10.1191/1478088706qp063oa · Cited by 194,414
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139 · cited 3×
“Additional exploratory analysis will also be undertaken to assess the consistency of treatment effect across the following subgroups: i) severity of depression and/or anxiety at baseline, according to MND-specific clinical cut-offs on the Hospital Anxiety and Depression Scale [51]; ii) patient preference for treatment…”
BackgroundMcKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Depression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
Hoffmann, T. C., Glasziou, P. P., Boutron, I., Milne, R., Perera, R., Moher, D., Altman, D. G., Barbour, V., Macdonald, H., Johnston, M., et al. (2014) · BMJ · doi:10.1136/bmj.g1687 · Cited by 10,548
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9903-x · Cited by 9,795
Statistical Analysis with Missing Data
Little, R. J. A., & Rubin, D. B. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781119013563 · Cited by 8,473
SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
Chan, A.-W., Tetzlaff, J. M., Altman, D. G., Laupacis, A., Gøtzsche, P. C., Krleža-Jerić, K., Hróbjartsson, A., Mann, H., Dickersin, K., Berlin, J. A., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-3-201302050-00583 · Cited by 7,363 · cited 1×
“Methods This protocol is reported in accordance with SPIRIT and TIDIER guidelines [36, 37].”
MethodRelatives of the Impaired Elderly: Correlates of Feelings of Burden
Zarit, S. H., Reever, K. E., & Bach-Peterson, J. (1980) · The Gerontologist · doi:10.1093/geront/20.6.649 · Cited by 5,810
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
Research works printed but not linked: 1
- Curtis L, Burns A. Unit costs of health and social care 2015. Personal Social Services Research Unit: University of Kent; 2015.
Cited by
Neuropsychological impairment in amyotrophic lateral sclerosis–frontotemporal spectrum disorder
Abrahams, S. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00878-z · Cited by 91
Gould, R. L., McDermott, C. J., Thompson, B. J., Rawlinson, C. V., Bursnall, M., Bradburn, M., Kumar, P., Turton, E. J., White, D. A., Serfaty, M. A., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00533-6 · Cited by 38
“16 This is due to its more pragmatic approach of helping people to live their lives in meaningful ways alongside the condition rather than focusing primarily on alleviating distress or symptoms, or thinking more realistically; strategies which might offer less scope for improvement given the…”
Self-citationBjelica, B., Bartels, M.-B., Hesebeck‐Brinckmann, J., & Petri, S. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12455-5 · Cited by 49
Brain Vascular Health in ALS Is Mediated through Motor Cortex Microvascular Integrity
Schreiber, S., Bernal, J., Arndt, P., Schreiber, F., Müller, P., Morton, L., Braun-Dullaeus, R. C., Hernández, M. V., Duarte, R., Wardlaw, J. M., et al. (2023) · Cells · doi:10.3390/cells12060957 · Cited by 34
Post-stroke emotionalism: Diagnosis, pathophysiology, and treatment
Broomfield, N. M., Blake, J., Gracey, F., & Steverson, T. (2024) · International Journal of Stroke · doi:10.1177/17474930241242952 · Cited by 15
Metadata
- Authors
- Gould, R. L., Thompson, B. J., Rawlinson, C., Kumar, P., White, D., Serfaty, M. A., Graham, C. D., McCracken, L. M., Bursnall, M., Bradburn, M., Young, T., Howard, R. J., Al-Chalabi, A., Goldstein, L. H., Lawrence, V., Cooper, C., Shaw, P. J., & McDermott, C. J.
- Affiliations
- University College London (GB)
- University of Sheffield (GB)
- Queen's University Belfast (GB)
- Uppsala University (SE)
- King's College London (GB)
- Corresponding author
- Gould, Rebecca L.
- ORCID
- Venue
- BMC Neurology
- Published
- 2022-11-15
- Volume
- 22
- Issue
- 1
- Pages
- 431-431
- ISSN
- 1471-2377 (ISSN-L)
- PMC
- PMC9664029
- OpenAlex
- W4309323790
- Semantic Scholar
- 11fc665f9c8ff754343c5ffe9ec6272b54120851
- Cited by
- 16
- References
- 65
- Citations by year
- 2026: 3 · 2024: 6 · 2023: 7
- FWCI
- 2.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- BMC Neurology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Research Portal (Queen's University Belfast) (acceptedVersion, other-oa)
- Strathprints: The University of Strathclyde institutional repository (University of Strathclyde) (acceptedVersion, other-oa)
- Research Portal (King's College London) (acceptedVersion, cc-by)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institute for Health and Care Research (16.81.01)
- Motor Neurone Disease Association (914225)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Keywords
- acceptance and commitment therapy, motor neuron disease, amyotrophic lateral sclerosis, mental health, psychological distress, quality of life, depression, anxiety, psychological flexibility, cost-effectiveness, usual care, progressive muscular atrophy, primary lateral sclerosis, resource utilization (health care), quality-adjusted life years, survival, treatment satisfaction, adverse events
- MeSH terms
- Cost-Benefit Analysis, Humans, Quality of Life, Randomized Controlled Trials as Topic, Motor Neuron Disease, Neurodegenerative Diseases, Acceptance and Commitment Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A randomised controlled trial of acceptance and commitment therapy plus usual care compared to usual care alone for improving psychological health in people with motor neuron disease (COMMEND): study protocol. https://app.cochat.ai/papers/10.1186/s12883-022-02950-5
- The paper
- Gould, R. L., Thompson, B. J., Rawlinson, C., Kumar, P., White, D., Serfaty, M. A., Graham, C. D., McCracken, L. M., Bursnall, M., Bradburn, M., Young, T., Howard, R. J., Al-Chalabi, A., Goldstein, L. H., Lawrence, V., Cooper, C., Shaw, P. J., & McDermott, C. J. (2022). A randomised controlled trial of acceptance and commitment therapy plus usual care compared to usual care alone for improving psychological health in people with motor neuron disease (COMMEND): study protocol. BMC Neurology. https://doi.org/10.1186/s12883-022-02950-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
